- Home
- PSNL
PSNL
Personalis Inc.
as 11-15-2024 4:00pm EST
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | FREMONT |
| Market Cap: | 321.1M | IPO Year: | 2019 |
| Target Price: | $6.81 | AVG Volume (30 days): | 845.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.71 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.02 - $7.20 | Next Earning Date: | 11-06-2024 |
| Revenue: | $87,489,000 | Revenue Growth: | 24.05% |
| Revenue Growth (this year): | 14.85% | Revenue Growth (next year): | 4.19% |
Stock Insider Trading Activity of Personalis Inc. (PSNL)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Hall Christopher M | PSNL | PRESIDENT AND CEO | Nov 1 '24 | Sell | $5.38 | 26,443 | $142,263.34 | 178,098 |
Latest Personalis Inc. News
PSNL Breaking Stock News: Dive into PSNL Ticker-Specific Updates for Smart Investing
Simply Wall St.
8 days ago
Here's Why We're Not Too Worried About Personalis' (NASDAQ:PSNL) Cash Burn Situation
Simply Wall St.
8 days ago
Personalis Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
GuruFocus.com
10 days ago
Personalis Inc (PSNL) Q3 2024 Earnings Call Highlights: Robust Revenue Growth Amid Strategic ...
Zacks
11 days ago
Personalis (PSNL) Reports Q3 Loss, Tops Revenue Estimates
Associated Press Finance
11 days ago
Personalis: Q3 Earnings Snapshot
Business Wire
11 days ago
Personalis Reports Third Quarter 2024 Financial Results
Business Wire
12 days ago
Personalis to Present at the Stifel 2024 Healthcare Conference
GuruFocus.com
12 days ago
Personalis Inc (PSNL) Q3 2024 Earnings Report Preview: What To Expect
Compare PSNL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PSNL Personalis Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.